Connection

Herman Goossens to Anti-Bacterial Agents

This is a "connection" page, showing publications Herman Goossens has written about Anti-Bacterial Agents.
Connection Strength

1.007
  1. Is there any difference in quality of prescribing between antibacterials and antifungals? Results from the first global point prevalence study (Global PPS) of antimicrobial consumption and resistance from 53 countries. J Antimicrob Chemother. 2017 10 01; 72(10):2906-2909.
    View in: PubMed
    Score: 0.146
  2. Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J Infect Dis. 2000 Jan; 181(1):235-41.
    View in: PubMed
    Score: 0.043
  3. Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients. J Antimicrob Chemother. 2019 11 01; 74(11):3264-3267.
    View in: PubMed
    Score: 0.042
  4. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019 07; 7(7):e861-e871.
    View in: PubMed
    Score: 0.041
  5. Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016). J Antimicrob Chemother. 2019 06 01; 74(6):1595-1606.
    View in: PubMed
    Score: 0.041
  6. Emergence of colistin resistance during treatment of recurrent pneumonia caused by carbapenemase producing Klebsiella pneumoniae. Diagn Microbiol Infect Dis. 2019 Aug; 94(4):407-409.
    View in: PubMed
    Score: 0.040
  7. Cost-effectiveness of internet-based training for primary care clinicians on antibiotic prescribing for acute respiratory tract infections in Europe. J Antimicrob Chemother. 2018 11 01; 73(11):3189-3198.
    View in: PubMed
    Score: 0.039
  8. Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Infect Control Hosp Epidemiol. 1998 Aug; 19(8):546-51.
    View in: PubMed
    Score: 0.039
  9. Using risk adjustment to improve the interpretation of global inpatient pediatric antibiotic prescribing. PLoS One. 2018; 13(7):e0199878.
    View in: PubMed
    Score: 0.039
  10. Metrics to assess the quantity of antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure. J Antimicrob Chemother. 2018 06 01; 73(suppl_6):vi59-vi66.
    View in: PubMed
    Score: 0.038
  11. Longitudinal point prevalence survey of antibacterial use in Northern Ireland using the European Surveillance of Antimicrobial Consumption (ESAC) PPS and Global-PPS tool. Epidemiol Infect. 2018 06; 146(8):985-990.
    View in: PubMed
    Score: 0.038
  12. Development of a prediction tool for patients presenting with acute cough in primary care: a prognostic study spanning six European countries. Br J Gen Pract. 2018 05; 68(670):e342-e350.
    View in: PubMed
    Score: 0.038
  13. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018 04 10; 115(15):E3463-E3470.
    View in: PubMed
    Score: 0.038
  14. Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study. Clin Microbiol Infect. 2018 Sep; 24(9):972-979.
    View in: PubMed
    Score: 0.037
  15. Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin. Eur J Clin Microbiol Infect Dis. 2018 Feb; 37(2):345-353.
    View in: PubMed
    Score: 0.037
  16. Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis by bacterial and viral aetiology. Clin Microbiol Infect. 2018 Aug; 24(8):871-876.
    View in: PubMed
    Score: 0.037
  17. Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey. Clin Infect Dis. 2017 May 15; 64(suppl_2):S61-S67.
    View in: PubMed
    Score: 0.036
  18. EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study. BMJ Open. 2017 04 03; 7(4):e015365.
    View in: PubMed
    Score: 0.035
  19. Disease Course of Lower Respiratory Tract Infection With a Bacterial Cause. Ann Fam Med. 2016 11; 14(6):534-539.
    View in: PubMed
    Score: 0.034
  20. In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2012 Mar; 56(3):1606-8.
    View in: PubMed
    Score: 0.025
  21. Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat. 2011 Apr; 14(2):95-106.
    View in: PubMed
    Score: 0.023
  22. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe. J Antimicrob Chemother. 2006 Aug; 58(2):413-7.
    View in: PubMed
    Score: 0.017
  23. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother. 2006 Aug; 58(2):418-22.
    View in: PubMed
    Score: 0.017
  24. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol. 2004 Oct; 42(10):4473-9.
    View in: PubMed
    Score: 0.015
  25. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg. 2021 10 01; 115(10):1122-1129.
    View in: PubMed
    Score: 0.012
  26. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J Glob Antimicrob Resist. 2021 06; 25:5-7.
    View in: PubMed
    Score: 0.012
  27. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc. 2020 07; 17(7):879-891.
    View in: PubMed
    Score: 0.011
  28. High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey. J Pediatric Infect Dis Soc. 2019 May 11; 8(2):143-151.
    View in: PubMed
    Score: 0.010
  29. Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan. BMC Health Serv Res. 2018 Nov 12; 18(1):849.
    View in: PubMed
    Score: 0.010
  30. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme. Vaccine. 2018 01 02; 36(1):15-22.
    View in: PubMed
    Score: 0.009
  31. Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Clin Microbiol Infect. 2017 Nov; 23(11):785-787.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.